Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes

Supporting evidence

• Surveillance report

• 2019 surveillance of medicines adherence (NICE guideline CG76) and medicines optimisation (NICE guideline NG5)

• Appendix A1: Summary of evidence from surveillance (medicines adherence) (PDF 1.13 MB)

  Published:

  27 March 2019

• Appendix B1: Stakeholder consultation comments table (medicines adherence) (PDF 782 KB)

  Published:

  27 March 2019

• Appendix A2: Summary of evidence from surveillance (medicines optimisation) (PDF 881 KB)

  Published:

  27 March 2019

• Appendix B2: Stakeholder consultation comments table (medicines optimisation) (PDF 660 KB)

  Published:

  27 March 2019

• Full guidance

• Appendices (PDF 8.41 MB)

  Published:

  04 March 2015

• Full guideline (PDF 2.76 MB)

  Published:

  04 March 2015